Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Dulaglutide (Primary) ; Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DUET-beta study
- 16 Nov 2017 Status changed from recruiting to completed.
- 06 Feb 2017 Status changed from not yet recruiting to recruiting.
- 30 Nov 2016 New trial record